Top Markets
#1 MowCat MowCat +48.73%
#2 Velvet Velvet +24.78%
#3 Fake World Assets Fake World Assets +24.13%
#4 Bitway Bitway +22.50%
#5 aPriori aPriori +21.20%
#6 OVERTAKE OVERTAKE +20.01%
#7 Biconomy Biconomy +17.12%
#8 Derive Derive +14.68%
#9 Audiera Audiera +13.62%
#10 Zerebro Zerebro +12.49%
Coin of the day
MowCat MowCat
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Eargo, Inc. Eargo, Inc.

Eargo, Inc.

EAR
Clasificación en acciones #34757
Eargo, Inc., a medical device firm, strives to improve the quality of life for... Eargo, Inc., a medical device firm, strives to improve the quality of life for individuals experiencing hearing impairment across the United States. The company focuses on developing and distributing hearing aids, utilizing both direct-to-consumer and extensive omni-channel sales approaches. Founded in 2010, the organization initially operated as Aria Innovations, Inc., before officially changing its name to Eargo, Inc. in November 2014. Its primary corporate hub is located in San Jose, California.
Precio por acción
$2.57
Última sincronización: 2024-02-23
Capitalización bursátil
$4.99M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Eargo, Inc. (EAR)

Categoría

Healthcare
Ganancias de Eargo, Inc. (EAR)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Eargo, Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Eargo, Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
$7.51B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
$5.15B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
$5.56B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
$3.86B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
$1.42B -
US